Takeda Pharmaceutical says it is developing coronavirus drug

Takeda Pharmaceutical Co Ltd is developing a drug to treat high-risk individuals infected with coronavirus, it said on Wednesday. The Japanese company said in a statement it is also studying whether it's currently marketed and pipeline products may be effective treatments for infected patients.

"As a company dedicated to the health and well-being of people around the world, we will do all that we can to address the novel coronavirus threat," Dr. Rajeev Venkayya, president of Takeda's vaccine business, said in a statement.